Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

Gianluca Spitaleri,1 Roberto Biffi,2 Massimo Barberis,3 Caterina Fumagalli,3 Francesca Toffalorio,1 Chiara Catania,1 Cristina Noberasco,1 Chiara Lazzari,1 Filippo de Marinis,1 Tommaso De Pas41Division of Chest Medical Oncology, 2Division of Abdominal Surgery, 3Division of Pathology, 4Oncology Unit o...

Full description

Bibliographic Details
Main Authors: Spitaleri G, Biffi R, Barberis M, Fumagalli C, Toffalorio F, Catania C, Noberasco C, Lazzari C, de Marinis F, De Pas T
Format: Article
Language:English
Published: Dove Medical Press 2015-08-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/inactivity-of-imatinib-in-gastrointestinal-stromal-tumors-gists-harbor-peer-reviewed-article-OTT

Internet

http://www.dovepress.com/inactivity-of-imatinib-in-gastrointestinal-stromal-tumors-gists-harbor-peer-reviewed-article-OTT

Similar Items